The company
Utrecht, Netherlands-based developer of an autonomous blood drawing device.
The funding
Vitestro, based in Utrecht, Netherlands, announced $70M in Series B financing on March 10, 2026.
Participants include Labcorp Venture Fund, Puma Venture Capital, NYBC Ventures, MGFO, Mayo Clinic, ROM Utrecht, Sonder Capital, PGGM, Fred Moll, EIC Fund, Invest-NL, InterVest, Sutter Health.